Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-23Dimensional and Developmental Approach to Psychotic Episodes in Children and Adolescents: Impact on Clinical Management
-
CLINICAL_TRIALS study record update · 2026-01-23European Long-acting Antipsychotics in Schizophrenia Trial-II
-
CLINICAL_TRIALS study record update · 2026-01-23Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-01-22Empirical Validation of a Cerebellar-cortical Hallucination Circuit
-
CLINICAL_TRIALS study record update · 2026-01-20A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-20Biomarkers in Clozapine-responding Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase 4, Single-Arm, Open-Label Study to Evaluate the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Subjects With Tardive Dyskinesia
-
CLINICAL_TRIALS study record update · 2026-01-15A Phase 1, Open-label, Single-sequence Pharmacokinetic Trial to Assess the Effect of a Single Oral Dose of SEP-380135 on the Potential for Cytochrome P4502D6 Mediated Drug-drug Interactions in Healthy Adults
-
CLINICAL_TRIALS study record update · 2026-01-14A Multicenter, Uncontrolled, Open-label Trial to Evaluate the Tolerability, Safety, and Efficacy of Long-term Administration of SEP-363856 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-14A 21-Week, Multicenter, Open-Label, Multiple-Dose Trial to Assess the Comparative Bioavailability of Olanzapine Prolonged-Release Suspension for Subcutaneous Administration (TV-44749) to Oral Olanzapine (European Reference) in Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-14Intermittent Theta Burst Stimulation of the Precuneus for the Treatment of Resistant Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-14Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
-
CLINICAL_TRIALS study record update · 2026-01-13Evaluation of the Effects of Transcranial Direct Current Stimulation on the Effectiveness of Cognitive Function Rehabilitation Using the RehaCom System in Patients With Schizophrenia (Study Protocol)
-
CLINICAL_TRIALS study record update · 2026-01-12Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet?
-
CLINICAL_TRIALS study record update · 2026-01-12Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
-
CLINICAL_TRIALS study record update · 2026-01-12The Use of Virtual Reality Application in Improving Psychosocial Dysfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-12A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Either Iloperidone Long-Acting Injection (LAI) or Placebo Injection
-
CLINICAL_TRIALS study record update · 2026-01-09A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy, Safety, and Tolerability of Olanzapine for Extended-Release Injectable Suspension (TV-44749) for Subcutaneous Use as Treatment of Adult Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-01-09TMS Related Biomarker Assessments
-
CLINICAL_TRIALS study record update · 2026-01-05Study on the Effectiveness of a Group Intervention on Romantic Relationships in Young Adults With Severe Mental Illness
-
CLINICAL_TRIALS study record update · 2026-01-02Characterization of Tachyphylaxis, Tolerance, and Withdrawal After Discontinuation of Igalmi in Frequently Agitated Schizophrenic or Bipolar Patients After 7 Days of PRN Treatment
-
CLINICAL_TRIALS study record update · 2026-01-02Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-12-31A Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-12-30Mindfulness-Based Psychoeducation Improves Mindfulness and Medication Adherence in Schizophrenia: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-12-30Efficacy of Personalized iTBS in Real-World Clinical Settings for Alleviating Schizophrenia Symptoms : A Randomized Single-Blind Trial